disease 2,995 words KG: ent-dise-7f7b1bd3
Contents

Aging-Related Tau Astrogliopathy (ARTAG)

Disease Info
PrevalenceFound in approximately 10-20% of cognitively normal elderly individuals
Full NameAging-Related Tau Astrogliopathy
AbbreviationARTAG
ClassificationNeurodegeneration / Tauopathy / Astrogliopathy
ICD-10 CodeG31.9 (Unspecified degenerative disease of nervous system)
AgePrimarily affects individuals over 70 years of age
Risk factorsAdvanced age is the primary risk factor
Gray matterSuperficial cortical layers (Layer 1-3), particularly in the frontal and temporal lobes
White matterPredominant white matter involvement
Subpial regionAlong the brain surface
Perivascular regionsAround small blood vessels
Common locationsFrontal cortex, temporal cortex, hippocampus
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Related Hypotheses (13)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76

Related Analyses (11)

What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · completed
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · completed

Related Experiments (6)

Tau depletion effects on neuronal development in primary cul
exploratory · proposed · Score: 0.90
Microtubule domain analysis in adult axons
exploratory · proposed · Score: 0.80
Pre-Symptomatic Tau Detection in MAPT Mutation Carriers
clinical · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)